Mar 2, 2026 07:04AM
Mar 2, 2026 07:00AM
Feb 27, 2026 04:30PM
Feb 26, 2026 07:01AM
Feb 26, 2026 07:00AM
Feb 24, 2026 07:00AM
Feb 11, 2026 05:54PM FDA approves NovoCure's Optune Pax for locally advanced pancreatic cancer
Feb 11, 2026 05:54PM
Jan 13, 2026 06:42AM
Jan 12, 2026 07:01AM
Jan 12, 2026 07:00AM
Dec 22, 2025 07:00AM
Dec 1, 2025 07:01AM
Dec 1, 2025 07:00AM Novocure Appoints Company President Frank Leonard as Chief Executive Officer
Nov 26, 2025 07:00AM
Nov 12, 2025 07:00AM
Oct 30, 2025 07:05AM
Oct 30, 2025 07:00AM
Oct 15, 2025 07:00AM
Oct 15, 2025 07:00AM
Oct 1, 2025 07:00AM Novocure to Report Third Quarter 2025 Financial Results
Sep 29, 2025 04:30PM
Sep 29, 2025 04:30PM
Sep 15, 2025 07:02AM
Sep 15, 2025 07:00AM
Aug 28, 2025 07:00AM
Aug 25, 2025 07:00AM
Aug 25, 2025 07:00AM Novocure Announces Coverage of Tumor Treating Fields (TTFields) Therapy for Patients with Newly Diagnosed Glioblastoma in Spain
Aug 20, 2025 07:01AM
Aug 20, 2025 07:00AM
Jul 24, 2025 07:01AM
Jul 24, 2025 07:00AM
Jul 1, 2025 07:00AM
Jun 30, 2025 07:00AM
May 31, 2025 08:00AM Results From the Phase 3 PANOVA-3 Trial of Novocure’s Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting
May 27, 2025 07:00AM
Apr 24, 2025 07:04AM
Apr 24, 2025 07:00AM
Apr 23, 2025 10:16AM
Apr 22, 2025 07:12AM
Apr 22, 2025 07:09AM
Apr 1, 2025 07:00AM Novocure to Report First Quarter 2025 Financial Results
Mar 4, 2025 07:00AM
Feb 27, 2025 07:06AM
Feb 27, 2025 07:00AM
Jan 22, 2025 04:00AM
Jan 13, 2025 07:06AM
Jan 13, 2025 07:00AM
Jan 3, 2025 07:00AM Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference
Dec 19, 2024 08:17AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All